Related Experiment Videos
[Steps in the treatment of ovarian cancer]
1Kliniki Onkologii Akademii Medycznej w Poznaniu.
Ginekologia Polska
|October 15, 1998
Abstract:
The paclitaxel/cisplatin regimen is superior to standard therapy PC based on higher overall response rates, higher negative second-look laparotomy rate and overall survival. The regimen paclitaxel/cisplatin/cyclophosphamide seem to give the best treatment results. Interval debulking surgery after initial laparotomy and intraperitoneal therapy with cisplatin and i.v. cyclophosphamide in patients with residual disease improve overall survival rate.